HYBRID EVENT: Join us in person in Orlando, Florida, USA or attend virtually from anywhere.

8th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2027 | Orlando, Florida, USA

Neurocognitive Testing in Addiction Disorders

Neurocognitive Testing in Addiction Disorders

Neurocognitive testing evaluates cognitive deficits commonly associated with addiction, such as impaired memory, attention, and executive functioning. Substance use often damages brain regions like the prefrontal cortex and hippocampus, leading to difficulties in decision-making, impulse control, and learning. Standardized tests, such as the Wisconsin Card Sorting Test and Stroop Test, help identify these impairments and guide personalized treatment plans. Neurocognitive assessments also aid in tracking recovery progress and predicting relapse risk. Integrating these evaluations into addiction care provides a comprehensive understanding of how substance use impacts brain function and highlights areas requiring cognitive rehabilitation.

Committee Members
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Christopher Ashton

Christopher Ashton

TeDDs on Chapel, Centre for Recovery, Canada
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - John J Giordano

John J Giordano

Life Enhancement Recovery Center, United States
Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2027 - Sam Vaknin

Sam Vaknin

Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Tags

Submit your abstract Today

Whatsapp